Want to join the conversation?
Provider of communications technology $FTR said that adjusting for dividends on the preferred stock, acquisition-related interest expense, acquisition and integration costs, severance costs and certain tax items, non-GAAP adjusted net income was $0.05 in 4Q15. Revenue was $1.41Bil, while total legacy revenue fell by $4MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.